Status:
COMPLETED
Prothrombin Complex Concentrate for Anticoagulant Reversal
Lead Sponsor:
CSL Behring
Conditions:
Acquired Coagulation Factor Deficiency
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Patients on oral anticoagulants need rapid reversal of the anticoagulant effect in case of acute bleeding or emergency surgery. Prothrombin Complex Concentrates are known to provide a fast reversal of...
Eligibility Criteria
Inclusion
- Key
- Subjects on oral anticoagulation requiring rapid reversal due to acute bleeding or emergency surgery
- INR \> 2 at baseline
- Key
Exclusion
- Acute thromboembolic event
- Treatment with any other investigational drug in the last 30 days before study entry
- Less than 2 weeks of stable oral anticoagulation
Key Trial Info
Start Date :
September 1 2005
Trial Type :
INTERVENTIONAL
End Date :
November 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00168077
Start Date
September 1 2005
End Date
November 1 2006
Last Update
February 11 2011
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trials Registration Coordinator
Feldkirch, Austria, 6800
2
Clinical Trials Registration Coordinator
Vienna, Austria, 1090
3
Clinical Trials Registration Coordinator
Halle, Germany, 06112
4
Clinical Trials Registration Coordinator
Hanover, Germany, 30623